Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Delayed ARIES
NCT06655376Phase 4Recruiting
- Sponsor
- Columbia University
- Start
- Oct 2024
- Primary completion
- Apr 2027
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Phase 4, randomised trial of aspirin in heart failure (HF) (2 arms), sponsored by Columbia University. Primary endpoint: Composite of Survival free of any major hemocompatibility related adverse event at 1 year. Started Oct 2024; status: recruiting.
02
Drugs
aspirin
03
Conditions
heart failure (HF)
Beyond the preview
Go deeper on NCT06655376.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06655376.